First salivary gland regenerative biobank developed to combat chronic dry mouth

Millions of people are affected by chronic dry mouth, or xerostomia, an agonizing side effect of damaged salivary glands. While chemotherapy and radiation treatment for head and neck cancer are the most common causes of this, aging, certain medications and other factors, including diabetes, stroke, Alzheimer’s disease and HIV/AIDS, can also cause chronic dry mouth. Currently, there is no cure for it.
Read More

AI-powered framework can predict the evolutionary fitness of SARS-CoV-2 variants

Viral infectious diseases pose significant challenges due to the rapid evolution of viruses through mutations. This was particularly evident during the COVID-19 pandemic, when emerging variants of SARS-CoV-2 sparked new waves of infection. These variants often carry mutations that make them more transmissible, allowing them to spread rapidly across populations.
Read More

Pulmonary fibrosis: Nerandomilast inhibits phosphodiesterase 4B, may treat multiple forms of disease

A new drug for pulmonary fibrosis has reduced disease progression by more than 50% over a 52-week treatment in two clinical trials. Pulmonary fibrosis is a very serious disease, with a life prognosis of 3 to 5 years after diagnosis. But the new drug, nerandomilast (Boehringer Ingelheim), could revolutionize the treatment of the disease after several failures of all potential new drugs tested for this disease in the last decade that have failed in phase 2 or phase 3 studies.
Read More
Top